Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brooks

Showing results (291-300 of 343) with videos related to

Pageof 35
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2026
Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84Mausam Kalita, Renesmee C Kuo, Valentina Straniero, et al.
EJNMMI Radiopharmacy and Chemistry|November 11, 2020
Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)Isaac M Jackson, So Jeong Lee, Alexandra R Sowa, et al.
Applied Optics|November 10, 2016
Overview of Advanced LIGO adaptive opticsAidan F Brooks, Benjamin Abbott, Muzammil A Arain, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
Nuclear Medicine and Biology|November 24, 2020
On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversionMatthias M Herth, Simon Ametamey, Dmitrii Antuganov, et al.
Nature|June 1, 2017
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosisUjjini H Manjunatha, Sumiti Vinayak, Jennifer A Zambriski, et al.
Cell Reports Methods|April 29, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentrationJakob Wirbel, Tessa M Andermann, Erin F Brooks, et al.
JAMA Internal Medicine|June 7, 2024
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical TrialLinda N Geng, Hector Bonilla, Haley Hedlin, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 35

Showing results (291-300 of 343) with videos related to

Sort By:
Pageof 35
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2026
Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84Mausam Kalita, Renesmee C Kuo, Valentina Straniero, et al.
EJNMMI Radiopharmacy and Chemistry|November 11, 2020
Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)Isaac M Jackson, So Jeong Lee, Alexandra R Sowa, et al.
Applied Optics|November 10, 2016
Overview of Advanced LIGO adaptive opticsAidan F Brooks, Benjamin Abbott, Muzammil A Arain, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
Nuclear Medicine and Biology|November 24, 2020
On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversionMatthias M Herth, Simon Ametamey, Dmitrii Antuganov, et al.
Nature|June 1, 2017
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosisUjjini H Manjunatha, Sumiti Vinayak, Jennifer A Zambriski, et al.
Cell Reports Methods|April 29, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentrationJakob Wirbel, Tessa M Andermann, Erin F Brooks, et al.
JAMA Internal Medicine|June 7, 2024
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical TrialLinda N Geng, Hector Bonilla, Haley Hedlin, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 35